Update on real-world efficacy of anlotinib in non-small cell lung cancer

被引：0
|
作者：
Gao, Junzhen
Xu, Yan
Liu, Yonggang
Liang, Li
Yu, Yan
Zhao, Dahai
Jin, Jiahui
Wang, Mengzhao
机构：
[1] Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China
[3] Baotou Tumor Hosp, Baotou, Peoples R China
[4] Peking Univ Third Hosp, Beijing, Peoples R China
[5] Harbin Med Canc Hosp, Harbin, Peoples R China
[6] Second Affiliated Hosp, Hefei, Peoples R China
[7] Affiliated Qingdao Cent Hosp, Qingdao, Peoples R China
[8] Peking Union Med Coll Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21173
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer
    Grady, Connor B.
    Hwang, Wei-Ting
    Reuss, Joshua E.
    Iams, Wade
    Cass, Amanda
    Liu, Geoffrey
    Patel, Devalben
    Liu, Stephen V.
    Montenegro, Gabriela Liliana Bravo
    Patil, Tejas
    Nieva, Jorge J.
    Herrmann, Amanda
    Marrone, Kristen A.
    Lam, Vincent K.
    Schwartzman, William
    Dowell, Jonathan
    Villaruz, Liza C.
    Miller, Kelsey Leigh
    Weiss, Jared
    Sun, Fangdi
    Velcheti, Vamsidhar
    Camidge, D. Ross
    Aggarwal, Charu
    Sun, Lova
    Marmarelis, Melina E.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (12)
  • [42] Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort study
    Hektoen, Helga H.
    Tsuruda, Kaitlyn M.
    Fjellbirkeland, Lars
    Nilssen, Yngvar
    Brustugun, Odd Terje
    Andreassen, Bettina K.
    BRITISH JOURNAL OF CANCER, 2025, 132 (01) : 93 - 102
  • [43] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Kellie J. Ryan
    Karen E. Skinner
    Ancilla W. Fernandes
    Rajeshwari S. Punekar
    Melissa Pavilack
    Mark S. Walker
    Noam A. VanderWalde
    Medical Oncology, 2019, 36
  • [44] EVALUATION OF DOCETAXEL USE IN NON-SMALL CELL LUNG CANCER: REAL-WORLD HEALTH OUTCOMES
    Merino Almazan, Macarena
    Marin Pozo, Juan Francisco
    Duarte Perez, Juan Manuel
    FARMACIA, 2021, 69 (03) : 419 - 425
  • [45] Impact of Maintenance Therapy for Patients with Non-small Cell Lung Cancer in a Real-world Setting
    Yoh, Kiyotaka
    Goto, Yasushi
    Naito, Yoichi
    Kishi, Kazuma
    Mori, Kiyoshi
    Hotta, Katsuyuki
    Hosomi, Yukio
    Yamada, Kazuhiko
    Tanai, Chiharu
    Tomizawa, Yoshio
    Inoue, Akira
    Hasegawa, Yoshinori
    Nishio, Makoto
    Ohashi, Yasuo
    Kunitoh, Hideo
    ANTICANCER RESEARCH, 2017, 37 (03) : 1507 - 1513
  • [46] Immunotherapy for non-small cell lung cancer: from clinical trials to real-world practice
    Rashdan, Sawsan
    Gerber, David E.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (03) : 202 - 207
  • [47] Real-world biomarker testing trends in metastatic non-small cell lung cancer (NSCLC).
    Clinton, Natasha
    Patel, Manish R.
    Ayars, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18728 - E18728
  • [48] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Ryan, Kellie J.
    Skinner, Karen E.
    Fernandes, Ancilla W.
    Punekar, Rajeshwari S.
    Pavilack, Melissa
    Walker, Mark S.
    VanderWalde, Noam A.
    MEDICAL ONCOLOGY, 2019, 36 (03)
  • [49] Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study
    Liguori, Luigi
    Giorgio, Gabriele
    Polcaro, Giovanna
    Pagliara, Valentina
    Malandrino, Domenico
    Perri, Francesco
    Cascella, Marco
    Ottaiano, Alessandro
    Conti, Valeria
    Servetto, Alberto
    Bianco, Roberto
    Pepe, Stefano
    Sabbatino, Francesco
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [50] Real-world treatment patterns for metastatic non-small cell lung cancer at IRST Italy
    Altini, M.
    Massa, I.
    Balzi, W.
    Gentili, N.
    Foca, F.
    Danesi, V.
    Manunta, S.
    Burgio, M. A.
    Cravero, P.
    Ejzykowicz, F.
    Chandwani, S.
    Delmonte, A.
    ANNALS OF ONCOLOGY, 2019, 30
12345